Compare Stellantis N.V. Common Shares (STLA) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Stellantis N.V. Common Shares vs Vir Biotechnology Inc. Common Stock — how do they compare? Stellantis N.V. Common Shares trades at $4.27 (market cap $16.51B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Stellantis N.V. Common Shares is far larger — about 9.2× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Stellantis N.V. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Stellantis N.V. Common Shares for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| STLA | VIR | |
|---|---|---|
Market Cap | $16.51B | $1.80B |
Volume | 28,274,156 | 1,782,836 |
Sector | Consumer Cyclical | Health |
52-Week High | $12.12 | $11.78 |
52-Week Low | $4.27 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $36.19B | $1.36B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Stellantis N.V. Common Shares
Stellantis N.V. is a multinational automaker formed from the 2021 merger of Fiat Chrysler Automobiles and PSA Group, manufacturing vehicles under brands including Jeep, Ram, Chrysler, Dodge, Fiat, Peugeot, and Citroën.
Read more on STLA →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
